Twelve Million Americans Lost Insurance Coverage for Weight Loss Drugs in 2026 as the GLP-1 Access Crisis Deepens
Over 12 million Americans lost commercial insurance coverage for Wegovy and similar GLP-1 drugs in 2026 as states, employers, and Medicaid programs retreat from obesity treatment.